Abstract

Malaria is a deadly disease caused by the apicomplexan parasite Plasmodium. Plasmodium asexual replication occurs in the red blood cell (RBC) and is what causes clinical symptoms of disease. In the RBC, Plasmodium moves through 3 developmental stages ending with schizogony and creating 16–32 daughter merozoites. At the end of schizogony, merozoites egress the host cell by breaking out of two membranes, the parasitophorous vacuole membrane and the RBC membrane. Schizogony and successful egress allows for exponential Plasmodium replication and RBC infection. Our lab recently identified a B3GLCT‐like protein in the Plasmodium ER (PfB3ER) that interacts with an essential ER chaperone and whose expression profile is similar to that of proteins required for egress. B3GLCT‐like proteins are known to act as glucosyltransferases and work in concert with protein O‐fucosyltransferases (POFUT2) to modify thrombospondin‐like repeats in mammalian cells. Surprisingly, the P. falciparum POFUT2 has been shown to be non‐essential while PfB3ER is predicted to be essential in the asexual stages. Based on PfB3ER homology to the mammalian B3GLCT and its predicted expression profile, we hypothesize that the O‐glycosylation function of PfB3ER is required for efficient egress of P. falciparum from RBCs. To test this, we have employed CRISPR/Cas9 gene editing to HA‐tag PfB3ER and create conditional mutants utilizing the TetR‐DOZI‐aptamer system. We show that PfB3ER localizes to the ER, unlike previous published results that suggest that PfB3ER is exported to the host RBC, and that PfB3ER is primarily expressed during schizogony. Further, we show that PfB3ER is essential for the asexual replication of P. falciparum. Future studies will focus on the specific stage of the intraerythrocytic lifecycle that are affected by PfB3ER knockdown and test the requirement of its glycosyltransferase activity. Together, these data have uncovered an essential function for a putative glycosyltransferase in the intraerythrocytic lifecycle of P. falciparum.Support or Funding Information R01 AI130139/AI/NIAID NIH HHS/United States

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call